Cancer Nanomedicine

This special issue brings together cutting edge research and insightful commentary on the currentl state of the Cancer Nanomedicine field.

Saved in:

Bibliographic Details
Other Authors:	Hoskins, Clare (Editor)
Format:	Electronic Book Chapter
Language:	English
Published:	Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2020
Subjects:	Technology: general issues antibody drug conjugate (ADC) PD-L1 tumor spheroid disruption immune modulation doxorubicin graphene oxide adsorption cathepsin D cathepsin L anti-metastatic enzyme cancer therapy nanoparticles targeted delivery system siRNA osteopontin mammary carcinoma mesenchymal stem cells (MSCs) TAT peptide PLGA paclitaxel nano-engineered MSCs orthotopic lung tumor model intracranial glioma immunotherapy CPMV viral nanoparticles in situ vaccine albumin nanoparticles microbubble ultrasound theranostics hepatocellular carcinoma VX2 tumor intra-arterial chemotherapy lung cancer nanomedicine clinical status cancer therapy breast cancer cell signaling active targeting passive targeting EPR effect oncogenes nanoparticle drug delivery ligand tumor targeting biodistribution Mesoporous silica nanoparticle drug delivery system target treatment lanthanide metal hyaluronic acid hyaluronidase drug combination everolimus dual-targeting magnetic nanoparticles monoclonal antibodies nanostructured lipid carrier platelet membrane biomimicry plasmonic photothermal therapy gold nanorods surgery bleeding dogs cats stimuli-responsive DOX SN38 CSCs single-walled carbon nanotubes chirality separation NASH drug-gene delivery near IR hyperspectral imaging plasmonics copper VEGF glioblastoma differentiated neuroblastoma peptidomimetics real-time quantitative polymerase chain reaction (qPCR) actin combinatorial therapy anticancer and antibacterial activity temoporfin drug-in-cyclodextrin-in-liposome hybrid nanoparticles multicellular tumor spheroids cyclodextrins photodynamic therapy article yet reasonably common within the subject discipline antitumor strategy biomimetic core-shell nanoparticles NK cell-derived exosomes folate receptor albumin nanoparticle microfluidic cabazitaxel polydopamine nanoparticles size cytotoxicity iron affinity FA-DABA-SMA self-assembly oncogenic proteins intracellular disruption folic receptor alpha pancreatic cancer parvifloron D albumin erlotinib photodynamic therapy lipid nanoparticles tumor vectorization verteporfin ovarian carcinomatosis spheroids integrin RGD peptide cancer diagnosis radiotherapy hyperthermia therapy biomimetic nanocarrier membrane-wrapped cancer targeted delivery photothermal therapy imaging cancer nanomedicine tumor microenvironment nano-bio interactions clinical translation magnetic nanowires magnetic hyperthermia magnetic actuation magnetic drug targeting titanate nanotubes gold nanoparticles vectorization colloidal stability docetaxel prostate cancer mangiferin anti-topoisomerase activity extracellular vesicles exosomes chemico-physical functionalization loading translational medicine nanotechnology: bioengineering anacardic acid mitoxantrone targeted drug delivery liposomes melanoma apoptosis ascorbic acid angiogenesis epithelial-to-mesenchymal transition hypoxia immunosuppression metabolism nanotherapeutics tumour microenvironment DNA origami liposome remote loading acute toxicity organoids magnetic silica-coated iron oxide nanochains photothermal treatment hyperthermia collagen cellular microenvironment lymphadenectomy magnetometer sentinel lymph node dissection SPION superparamagnetic iron oxide nanoparticles Vδ2 T cells zoledronic acid polymeric nanoconstruct anti-tumor immunity colorectal carcinoma β-cyclodextrin nanosponges BALB-neuT mice brain tumours glioma blood brain barrier polymeric nanoparticles PEGylation dioleoylphosphatidylethanolamine poly(hydroxyethyl acrylate-co-allyl methyl sulfide) copolymer folate oxidation-sensitive release cellular interaction in vitro anti-cancer activity triple negative breast cancer organotin mesoporous silica nanoparticles MDA-MB-231 theranostic nanomaterials nanobiotechnology molecular imaging nanosystems nanomicelles ovarian cancer tumour targeting chemotherapeutics riboflavin vitamin B2 nanomedicines secondary structure mixed micelle pH responsive targeted therapy anti-cancer shear stress flow in vitro therapeutics diagnostics Immunotherapy
Online Access:	DOAB: download the publication DOAB: description of the publication
Tags:	Add Tag No Tags, Be the first to tag this record!

MARC


LEADER	00000naaaa2200000uu 4500
001	doab_20_500_12854_69077
005	20210501
003	oapen
006	m o d
007	cr\|mn\|---annan
008	20210501s2020 xx \|\|\|\|\|o \|\|\| 0\|eng d
020			\|a books978-3-03943-059-8
020			\|a 9783039430581
020			\|a 9783039430598
040			\|a oapen \|c oapen
024	7		\|a 10.3390/books978-3-03943-059-8 \|c doi
041	0		\|a eng
042			\|a dc
072		7	\|a TB \|2 bicssc
100	1		\|a Hoskins, Clare \|4 edt
700	1		\|a Hoskins, Clare \|4 oth
245	1	0	\|a Cancer Nanomedicine
260			\|a Basel, Switzerland \|b MDPI - Multidisciplinary Digital Publishing Institute \|c 2020
300			\|a 1 electronic resource (510 p.)
336			\|a text \|b txt \|2 rdacontent
337			\|a computer \|b c \|2 rdamedia
338			\|a online resource \|b cr \|2 rdacarrier
506	0		\|a Open Access \|2 star \|f Unrestricted online access
520			\|a This special issue brings together cutting edge research and insightful commentary on the currentl state of the Cancer Nanomedicine field.
540			\|a Creative Commons \|f https://creativecommons.org/licenses/by/4.0/ \|2 cc \|4 https://creativecommons.org/licenses/by/4.0/
546			\|a English
650		7	\|a Technology: general issues \|2 bicssc
653			\|a antibody drug conjugate (ADC)
653			\|a PD-L1
653			\|a tumor spheroid disruption
653			\|a immune modulation
653			\|a doxorubicin
653			\|a graphene oxide
653			\|a adsorption
653			\|a cathepsin D
653			\|a cathepsin L
653			\|a anti-metastatic enzyme cancer therapy
653			\|a nanoparticles
653			\|a targeted delivery system
653			\|a siRNA
653			\|a osteopontin
653			\|a mammary carcinoma
653			\|a mesenchymal stem cells (MSCs)
653			\|a TAT peptide
653			\|a PLGA
653			\|a paclitaxel
653			\|a nano-engineered MSCs
653			\|a orthotopic lung tumor model
653			\|a intracranial glioma
653			\|a immunotherapy
653			\|a CPMV
653			\|a viral nanoparticles
653			\|a in situ vaccine
653			\|a albumin nanoparticles
653			\|a microbubble
653			\|a ultrasound
653			\|a theranostics
653			\|a hepatocellular carcinoma
653			\|a VX2 tumor
653			\|a intra-arterial chemotherapy
653			\|a lung cancer
653			\|a nanomedicine
653			\|a clinical status
653			\|a cancer therapy
653			\|a breast cancer
653			\|a cell signaling
653			\|a active targeting
653			\|a passive targeting
653			\|a EPR effect
653			\|a oncogenes
653			\|a nanoparticle
653			\|a drug delivery
653			\|a ligand
653			\|a tumor targeting
653			\|a biodistribution
653			\|a Mesoporous silica nanoparticle
653			\|a drug delivery system
653			\|a target treatment
653			\|a lanthanide metal
653			\|a hyaluronic acid
653			\|a hyaluronidase
653			\|a drug combination
653			\|a everolimus
653			\|a dual-targeting
653			\|a magnetic nanoparticles
653			\|a monoclonal antibodies
653			\|a nanostructured lipid carrier
653			\|a platelet membrane
653			\|a biomimicry
653			\|a plasmonic photothermal therapy
653			\|a gold nanorods
653			\|a surgery
653			\|a bleeding
653			\|a dogs
653			\|a cats
653			\|a stimuli-responsive
653			\|a DOX
653			\|a SN38
653			\|a CSCs
653			\|a single-walled carbon nanotubes
653			\|a chirality separation
653			\|a NASH
653			\|a drug-gene delivery
653			\|a near IR hyperspectral imaging
653			\|a plasmonics
653			\|a copper
653			\|a VEGF
653			\|a glioblastoma
653			\|a differentiated neuroblastoma
653			\|a peptidomimetics
653			\|a real-time quantitative polymerase chain reaction (qPCR)
653			\|a actin
653			\|a combinatorial therapy
653			\|a anticancer and antibacterial activity
653			\|a temoporfin
653			\|a drug-in-cyclodextrin-in-liposome
653			\|a hybrid nanoparticles
653			\|a multicellular tumor spheroids
653			\|a cyclodextrins
653			\|a photodynamic therapy article
653			\|a yet reasonably common within the subject discipline
653			\|a antitumor strategy
653			\|a biomimetic core-shell nanoparticles
653			\|a NK cell-derived exosomes
653			\|a folate receptor
653			\|a albumin nanoparticle
653			\|a microfluidic
653			\|a cabazitaxel
653			\|a polydopamine nanoparticles
653			\|a size
653			\|a cytotoxicity
653			\|a iron affinity
653			\|a FA-DABA-SMA
653			\|a self-assembly
653			\|a oncogenic proteins
653			\|a intracellular disruption
653			\|a folic receptor alpha
653			\|a pancreatic cancer
653			\|a parvifloron D
653			\|a albumin
653			\|a erlotinib
653			\|a photodynamic therapy
653			\|a lipid nanoparticles
653			\|a tumor vectorization
653			\|a verteporfin
653			\|a ovarian carcinomatosis
653			\|a spheroids
653			\|a integrin
653			\|a RGD peptide
653			\|a cancer diagnosis
653			\|a radiotherapy
653			\|a hyperthermia therapy
653			\|a biomimetic
653			\|a nanocarrier
653			\|a membrane-wrapped
653			\|a cancer
653			\|a targeted delivery
653			\|a photothermal therapy
653			\|a imaging
653			\|a cancer nanomedicine
653			\|a tumor microenvironment
653			\|a nano-bio interactions
653			\|a clinical translation
653			\|a magnetic nanowires
653			\|a magnetic hyperthermia
653			\|a magnetic actuation
653			\|a magnetic drug targeting
653			\|a titanate nanotubes
653			\|a gold nanoparticles
653			\|a vectorization
653			\|a colloidal stability
653			\|a docetaxel
653			\|a prostate cancer
653			\|a mangiferin
653			\|a anti-topoisomerase activity
653			\|a extracellular vesicles
653			\|a exosomes
653			\|a chemico-physical functionalization
653			\|a loading
653			\|a translational medicine
653			\|a nanotechnology: bioengineering
653			\|a anacardic acid
653			\|a mitoxantrone
653			\|a targeted drug delivery
653			\|a liposomes
653			\|a melanoma
653			\|a apoptosis
653			\|a ascorbic acid
653			\|a angiogenesis
653			\|a epithelial-to-mesenchymal transition
653			\|a hypoxia
653			\|a immunosuppression
653			\|a metabolism
653			\|a nanotherapeutics
653			\|a tumour microenvironment
653			\|a DNA origami
653			\|a liposome
653			\|a remote loading
653			\|a acute toxicity
653			\|a organoids
653			\|a magnetic silica-coated iron oxide nanochains
653			\|a photothermal treatment
653			\|a hyperthermia
653			\|a collagen
653			\|a cellular microenvironment
653			\|a lymphadenectomy
653			\|a magnetometer
653			\|a sentinel lymph node dissection
653			\|a SPION
653			\|a superparamagnetic iron oxide nanoparticles
653			\|a Vδ2 T cells
653			\|a zoledronic acid
653			\|a polymeric nanoconstruct
653			\|a anti-tumor immunity
653			\|a colorectal carcinoma
653			\|a β-cyclodextrin nanosponges
653			\|a BALB-neuT mice
653			\|a brain tumours
653			\|a glioma
653			\|a blood brain barrier
653			\|a polymeric nanoparticles
653			\|a PEGylation
653			\|a dioleoylphosphatidylethanolamine
653			\|a poly(hydroxyethyl acrylate-co-allyl methyl sulfide) copolymer
653			\|a folate
653			\|a oxidation-sensitive release
653			\|a cellular interaction
653			\|a in vitro anti-cancer activity
653			\|a triple negative breast cancer
653			\|a organotin
653			\|a mesoporous silica nanoparticles
653			\|a MDA-MB-231
653			\|a theranostic nanomaterials
653			\|a nanobiotechnology
653			\|a molecular imaging
653			\|a nanosystems
653			\|a nanomicelles
653			\|a ovarian cancer
653			\|a tumour targeting
653			\|a chemotherapeutics
653			\|a riboflavin
653			\|a vitamin B2
653			\|a nanomedicines
653			\|a secondary structure
653			\|a mixed micelle
653			\|a pH responsive
653			\|a targeted therapy
653			\|a anti-cancer
653			\|a shear stress
653			\|a flow
653			\|a in vitro
653			\|a therapeutics
653			\|a diagnostics
653			\|a Immunotherapy
856	4	0	\|a www.oapen.org \|u https://mdpi.com/books/pdfview/book/2846 \|7 0 \|z DOAB: download the publication
856	4	0	\|a www.oapen.org \|u https://directory.doabooks.org/handle/20.500.12854/69077 \|7 0 \|z DOAB: description of the publication

Cancer Nanomedicine

MARC

Similar Items